Viewing Study NCT03052933


Ignite Creation Date: 2025-12-25 @ 2:43 AM
Ignite Modification Date: 2026-02-28 @ 7:10 PM
Study NCT ID: NCT03052933
Status: COMPLETED
Last Update Posted: 2022-06-10
First Post: 2017-02-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Copanlisib and Gemcitabine in Relapsed/Refractory PTCL
Sponsor: Chonnam National University Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Mature T-Cell and NK-Cell Neoplasm View
Keywords:

Keywords

Keyword Brief Keyword Text View
None copanlisib View
None gemcitabine View
None peripheral T-cell lymphoma View
None extranodal NK/T-cell lymphoma View